Cambridge Brain Mets Trial 1

计划入组 26 人 · 首次发布于 2016 年 5 月 11 日

Generalist Cohort of Migrant Patients Consultants in City Medicine

计划入组 197 人 · 首次发布于 2021 年 8 月 4 日

Prevalence of Musculoskeletal Symptoms in the Cambridge NIHR BioResource

计划入组 5,000 人 · 首次发布于 2020 年 11 月 17 日

Allogeneic neural stem cells therapy(University of Cambridge)

PON-3 (Cambridge University)

MAb32 (Cambridge Antibody Technology)

Cambridge Theranostics Ltd.

United Kingdom

Summit (Cambridge) Ltd.

United Kingdom

BenevolentAI Cambridge Ltd.

United Kingdom

Janssen to Address Key Challenges in Drug-Device Combination Product Development at Pre-Filled Syringes Conference

CS Diagnostics Enlists Lachman Consultants to Secure FDA Approval for Novel Cancer Treatment Hydrogel

Cambridge Cognition Secures Major Contract for Schizophrenia Trial